AKT1 and leiomyoma: With the progression of ECM deposition, intracellular signaling pathways are triggered, such as the mitogen-activated protein kinase (MAPK) and PI3K/Akt (protein kinase B (PKB)) pathways, which increase proliferation and cell survival and maintain the ECM’s deposition microenvironment in leiomyoma [15,16].